Boryung Pharm
Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, So… Read more
Boryung Pharm (003850) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.060x
Based on the latest financial reports, Boryung Pharm (003850) has a cash flow conversion efficiency ratio of 0.060x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩48.95 Billion) by net assets (₩818.35 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Boryung Pharm - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how Boryung Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Boryung Pharm Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Boryung Pharm ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PERMA-PIPE INTL HLDGS
F:MF3
|
N/A |
|
John Mattson Fastighetsforetagen AB
ST:JOMA
|
0.008x |
|
Vizionfocus Inc.
TW:4771
|
0.059x |
|
Steyr Motors AG
VI:4X0
|
N/A |
|
Protara Therapeutics Inc
NASDAQ:TARA
|
-0.094x |
|
C4 Therapeutics Inc
NASDAQ:CCCC
|
-0.086x |
|
Curacle Co. Ltd.
KQ:365270
|
-0.092x |
|
NEXCOM International Co Ltd
TWO:8234
|
0.017x |
Annual Cash Flow Conversion Efficiency for Boryung Pharm (2009–2024)
The table below shows the annual cash flow conversion efficiency of Boryung Pharm from 2009 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩784.50 Billion | ₩80.56 Billion | 0.103x | +33.57% |
| 2023-12-31 | ₩549.25 Billion | ₩42.22 Billion | 0.077x | +42.73% |
| 2022-12-31 | ₩516.42 Billion | ₩27.81 Billion | 0.054x | -57.54% |
| 2021-12-31 | ₩474.31 Billion | ₩60.17 Billion | 0.127x | -3.52% |
| 2020-12-31 | ₩340.29 Billion | ₩44.74 Billion | 0.131x | -20.84% |
| 2019-12-31 | ₩282.95 Billion | ₩47.00 Billion | 0.166x | +9.32% |
| 2018-12-31 | ₩256.10 Billion | ₩38.91 Billion | 0.152x | +254.12% |
| 2017-12-31 | ₩249.65 Billion | ₩-24.61 Billion | -0.099x | -305.69% |
| 2016-12-31 | ₩195.35 Billion | ₩9.36 Billion | 0.048x | -61.98% |
| 2012-12-31 | ₩145.79 Billion | ₩18.38 Billion | 0.126x | +89.34% |
| 2011-12-31 | ₩137.97 Billion | ₩9.19 Billion | 0.067x | -62.35% |
| 2010-12-31 | ₩136.41 Billion | ₩24.12 Billion | 0.177x | +510.22% |
| 2009-12-31 | ₩124.01 Billion | ₩3.59 Billion | 0.029x | -- |